These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18940742)

  • 21. Faithfull modeling of PTEN loss driven diseases in the mouse.
    Nardella C; Carracedo A; Salmena L; Pandolfi PP
    Curr Top Microbiol Immunol; 2010; 347():135-68. PubMed ID: 20549475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
    Cully M; You H; Levine AJ; Mak TW
    Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice.
    Chen J; Zhang XD; Proud C
    Sci Signal; 2015 Sep; 8(392):pe1. PubMed ID: 26329580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dermatological implications of the PI3K pathway].
    Dereure O
    Ann Dermatol Venereol; 2015 Oct; 142(10):622-3. PubMed ID: 26001484
    [No Abstract]   [Full Text] [Related]  

  • 26. Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells.
    Wu Z; Conaway M; Gioeli D; Weber MJ; Theodorescu D
    Prostate; 2006 Jul; 66(10):1114-23. PubMed ID: 16637073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.
    Chun SH; Jung CK; Won HS; Kang JH; Kim YS; Kim MS
    Head Neck; 2015 May; 37(5):636-43. PubMed ID: 24616007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular mechanism in pathogenesis of pancreatic neoplasms: p-Akt, PTEN].
    Ozaki Y; Tatebe S; Ikeguchi M
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():41-3. PubMed ID: 16457218
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer.
    Jouali F; Marchoudi N; Talbi S; Bilal B; El Khasmi M; Rhaissi H; Fekkak J
    BMC Cancer; 2018 Sep; 18(1):900. PubMed ID: 30227836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells.
    Akca H; Demiray A; Tokgun O; Yokota J
    Lung Cancer; 2011 Sep; 73(3):302-9. PubMed ID: 21333374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic PTEN functions and models in T-cell malignancies.
    Tesio M; Trinquand A; Macintyre E; Asnafi V
    Oncogene; 2016 Jul; 35(30):3887-96. PubMed ID: 26616857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
    Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse models to decipher the PI3K signaling network in human cancer.
    Renner O; Carnero A
    Curr Mol Med; 2009 Jun; 9(5):612-25. PubMed ID: 19601810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Akt-regulated pathways in prostate cancer.
    Majumder PK; Sellers WR
    Oncogene; 2005 Nov; 24(50):7465-74. PubMed ID: 16288293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional roles of Akt signaling in mouse skin tumorigenesis.
    Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martínez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
    Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
    Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.
    Liu Z; Hou P; Ji M; Guan H; Studeman K; Jensen K; Vasko V; El-Naggar AK; Xing M
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3106-16. PubMed ID: 18492751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The conserved PI3'K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila.
    Scanga SE; Ruel L; Binari RC; Snow B; Stambolic V; Bouchard D; Peters M; Calvieri B; Mak TW; Woodgett JR; Manoukian AS
    Oncogene; 2000 Aug; 19(35):3971-7. PubMed ID: 10962553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
    Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.